Genomics

AI brain
#CNS #Events #Genomics #Neuroscience #SLAS2025

Learn about the brain genomic positioning system with DDW

Graham T Dempsey, PhD, Co-founder and Chief Scientific Officer, Quiver Biosciences will be speaking at the DDW SLAS2025 track – Concept to Cure: Curiosity and Lab Automation in Drug Discovery. SLAS2025 is on 25-29 January 2025, in San Diego, USA. Graham Dempsey This free… Read More

#News

#Collaboration #Genomics #Genomics England #NHS #Public health #Research #Revvity

Collaboration to advance UK genomics research 

Revvity has announced an expansion of its working relationship with Genomics England that leverages both organisations' expertise and resources to advance critical genomic initiatives across the United Kingdom.   Building on the parties’ long and productive work history, this collaboration is dedicated to accelerating Genomics England’s research programmes, supporting diverse areas… Read More

#Business & Investment #News

Human cells
#Drug delivery #Genomics #Oncology #Personalised medicine #Spatial biology

The opportunity for spatial biology in drug discovery  

DDW Editor Reece Armstrong speaks to Ellie Mahjubi, Vice President, Protein and cell analysis at Thermo Fisher Scientific, about how spatial biology is impacting drug discovery and development research.   RA: What’s the future and potential for spatial biology?  EM: Technological advancements in spatial biology are providing unprecedented insights into… Read More

#Exclusive Content

CRISPR gene editing
#Collaboration #CRISPR-Cas9 #ERS Genomics #Genomics #Medicines Discovery Catapult (MDC)

ERS Genomics and MDC sign CRISPR/Cas9 license agreement

ERS Genomics and not-for-profit Medicines Discovery Catapult (MDC) have signed a non-exclusive commercial-use CRISPR license agreement. The partnership hopes to combine ERS’s CRISPR/Cas9 patent portfolio with MDC’s expertise and technology. As part of the deal, MDC and its partners will benefit from access to ERS’ CRISPR/Cas9 portfolio – the foundational… Read More

#Business & Investment #News

CRISPR gene editing
#AstraZeneca #Cancer Research Horizons #CRISPR #Genomics #Partnership

AZ and Cancer Research Horizons extend genomics partnership

Cancer Research Horizons and AstraZeneca have signed a five-year renewal of the Functional Genomics Centre, a facility dedicated to advancing drug discovery with genome-altering technologies such as CRISPR. The Functional Genomics Centre was established in 2019 to explore the function and interaction of genes and proteins… Read More

#News

#Genomics #RNA biology #RNA Therapeutics #Serna Bio #Small molecules #Transcriptomics

The untapped potential of the transcriptome  

Serna Bio was founded by Rabia Khan, who is also the CEO, to unlock the transcriptome as a drug discovery target. DDW’s Megan Thomas speaks to Khan about the work her team is doing to create the first map of the druggable transcriptome, which involves understanding RNA biology to discover… Read More

#Exclusive Content #Opinion

#Epigenetics #Genomics #Multiomics #Nanopore sequencing #Omics #Proteomics #Transcriptomics

Multiomics sequencing: Find out what you’re missing

Download this new brochure ‘Multiomic nanopore sequencing solutions: Revolutionising human disease research‘ to maximise the data generated from your valuable research samples. Understanding the mechanisms of disease requires complex data ranging from genomic data through to transcriptomics, epigenetics and proteomics. Legacy multiomic approaches require multiple platforms… Read More

#News

#Epigenetics #Genomics #Multiomics #Nanopore sequencing #Omics #Proteomics #Transcriptomics

Multiomics sequencing: How to maximise the data generated from valuable research samples

Understanding the mechanisms of disease requires complex data ranging from genomic data through to transcriptomics, epigenetics and proteomics. Legacy multiomic approaches require multiple platforms and complex processes, which are incompatible with disease research that utilises scarce tissue samples. Download the brochure to learn how multiomic nanopore sequencing can… Read More

#Resources

#Amyotrophic lateral sclerosis (ALS) #Biotechnology #Broken String Biosciences #DNA #Francis Crick Institute #Genomics

UK industry collaboration to advance ALS research 

Broken String Biosciences has entered a research collaboration with the Francis Crick Institute, focused on leveraging technology to investigate the impact of genomic instability in the development of amyotrophic lateral sclerosis (ALS).  The aim to achieve this is through the development of novel applications for Broken String’s… Read More

#News

#Biobanking #Genome sequencing #Genomics #PacBio #Public health #Whole genome sequencing

Estonia National Biobank to sequence 10,000 whole genomes 

PacBio has announced that the University of Tartu, host of Estonia’s National Biobank, has chosen the company’s Revio HiFi sequencing system to sequence 10,000 whole human genomes and unlock new insights from its population health data.    The announcement follows funding from the European Commission and… Read More

#News

DNA research molecule
#CAR-T #DNA #Epigenomics #Genetic editing #Genomics #Immunology #Oncology #Tune Therapeutic

Moving the needle of CAR-T beyond oncology 

CAR-T Therapies have revolutionised the field of personalised medicine, especially in oncology. DDW’s Megan Thomas speaks with Dr Blythe Sather, Vice President and Head of Research at Tune Therapeutics, about how genetic tuning will transform the reach for CAR-T therapies, the different diseases that can benefit, and the disruptive technology making… Read More

#Cancer Research #Exclusive Content

Scientific technology
#AI / data analytics / healthtech / informatics #Clinical development #Data automation #Data management #Diagnostics #Drug discovery #Electronic Lab Notebooks (ELN) #FAIR Principles #Genomics #Immunology / Virology & Vaccines #Infectious diseases #Informatics #mRNA #Personalised medicine #Precision medicine #Predictive diagnostics #Public health

New podcast: Revolutionary technology for drug discovery

This is the latest episode of the free DDW narrated podcast, titled “Revolutionary technology for drug discovery and development” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: mRNA technology may hold the future for a cytomegalovirus vaccine; … Read More

#News

AI genomics concept
#AI / data analytics / healthtech / informatics #Biobanking #Genomics #Personalised medicine

Supercharging AI-drug discovery with strategic multiomic biobanks 

Niven R. Narain, PhD, President and CEO of BPGbio asks how a better calibre of biobanks in life sciences can lead to more drugs making it to market.   Artificial Intelligence (AI) has become a popular buzzword in the drug discovery and development lexicon but not all approaches to AI-driven… Read More

#Exclusive Content

#Evotec #Genomics #High throughput screening #Metabolomics #Multi-omics #Proteomics #Transcriptomics

PanOmics: Advancing drug discovery

This article is sponsored by Evotec. To enable Evotec’s precision medicine approach, we have been building technology platforms that allow PanOmics or multi-omics data generation at an industrialised scale. The technologies cover the whole range of biomolecules from genes to protein to metabolites. While we are using… Read More

#News

#AI / data analytics / healthtech / informatics #Covid-19 #Genomics #Machine learning #Microfluidics

New podcast: Reaching new heights with drug discovery

This is the latest episode of the free DDW narrated podcast, “Reaching new heights with drug discovery”. It covers two articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “High-throughput technologies: Reaching for the stars” and “… Read More

#News

Genomics
#Europe #Genetics / genomics #Genomics #Immunotherapy #Oncology #Personalised medicine #The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)

Coalition will promote access to genomic profiling in Europe

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), Exact Sciences, Guardant Health, Illumina, MSD and Novartis have come together to launch the European Coalition for Access to Comprehensive Genomic Profiling (ECGP). It is hoped that the Coalition will improve cancer care through increased routine clinical access and… Read More

#News